4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (CML)

Details for Australian Patent Application No. 2004289243 (hide)

Owner Wyeth LLC

Inventors Boschelli, Frank Charles; Arndt, Kim Timothy; Golas, Jennifer Michele

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004289243

PCT Pub. Number WO2005/046693

Priority 60/517,819 06.11.03 US

Filing date 3 November 2004

Wipo publication date 26 May 2005

Acceptance publication date 22 July 2010

International Classifications

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

C07D 215/54 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

25 May 2006 PCT application entered the National Phase

  PCT publication WO2005/046693 Priority application(s): WO2005/046693

22 July 2010 Application Accepted

  Published as AU-B-2004289243

18 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004289247-Compositions and methods for diagnosing and treating mental disorders

2004289241-Adjuvant blend for spray on fruit or foliage